{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:16:35Z","timestamp":1789193795870,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.pcad.2009.12.003","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T02:02:58Z","timestamp":1269223378000},"page":"393-400","source":"Crossref","is-referenced-by-count":75,"title":["Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System"],"prefix":"10.1016","volume":"52","author":[{"given":"John W.","family":"Funder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2009.12.003_bib1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1172\/JCI104436","article-title":"Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro","volume":"40","author":"Crabbe","year":"1961","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2009.12.003_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI104301","article-title":"Evidence for a secretion of an aldosterone stimulating hormone from the kidney","volume":"40","author":"Davis","year":"1961","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2009.12.003_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI104492","article-title":"The role of the renin angiotensin system in the control of aldosterone secretion","volume":"41","author":"Davis","year":"1962","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2009.12.003_bib4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pcad.2009.12.003_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2005-0004","article-title":"The nongenomic actions of aldosterone","volume":"26","author":"Funder","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pcad.2009.12.003_bib6","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","article-title":"Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity","volume":"80","author":"Krozowski","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2009.12.003_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1440-1681.1987.tb02422.x","article-title":"High affinity aldosterone binding sites (type 1 receptors) in rat heart","volume":"14","author":"Pearce","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pcad.2009.12.003_bib8","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/en.137.12.5264","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinol"},{"key":"10.1016\/j.pcad.2009.12.003_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.pcad.2009.12.003_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2009.12.003_bib11","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo-125-4-2224","article-title":"Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors","volume":"125","author":"Funder","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.pcad.2009.12.003_bib12","first-page":"3","article-title":"Primary aldosteronism: a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.pcad.2009.12.003_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2009.12.003_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119249","article-title":"Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion","volume":"99","author":"Okubo","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2009.12.003_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9150(02)00363-5","article-title":"Aldosterone induces contraction of the resistance arteries in man","volume":"166","author":"Romagni","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2009.12.003_bib16","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","article-title":"Distinguishing the antihypertensive and electrolyte effects of eplerenone","volume":"89","author":"Levy","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2009.12.003_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ajh\/4.4.374","article-title":"What is the role of the central nervous system in mineralocorticoid hypertension","volume":"4","author":"Gomez-Sanchez","year":"1991","journal-title":"Am J Hyperten"},{"issue":"4 Pt 1","key":"10.1016\/j.pcad.2009.12.003_bib18","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol"},{"issue":"3 Pt 1","key":"10.1016\/j.pcad.2009.12.003_bib19","first-page":"E482","article-title":"Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol"},{"issue":"1 Pt 1","key":"10.1016\/j.pcad.2009.12.003_bib20","first-page":"E96","article-title":"Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S\/JR rats","volume":"262","author":"Gomez-Sanchez","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pcad.2009.12.003_bib21","article-title":"Effect of 3beta hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt sensitive rat","author":"Gomez-Sanchez","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pcad.2009.12.003_bib22","doi-asserted-by":"crossref","unstructured":"Huang BS, White RA, Jeng AY, et al: Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol (First published December 31, 2008), doi:10.1152\/ajpregu.90903.2008.","DOI":"10.1152\/ajpregu.90903.2008"},{"key":"10.1016\/j.pcad.2009.12.003_bib23","first-page":"R356","article-title":"How do central mineralocorticoid receptors modulate blood pressure?","volume":"288","author":"Funder","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pcad.2009.12.003_bib24","doi-asserted-by":"crossref","first-page":"R992","DOI":"10.1152\/ajpregu.00071.2009","volume":"296","author":"Funder","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pcad.2009.12.003_bib25","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/00004872-200209000-00029","article-title":"Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats","volume":"20","author":"Rahmouni","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.003_bib26","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis and treatment of patients with primary aldosteronism","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2009.12.003_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1378\/chest.125.1.112","article-title":"Aldosterone secretion among patients with resistant hypertension and symptoms of sleep apnea","volume":"125","author":"Calhoun","year":"2004","journal-title":"CHEST"},{"key":"10.1016\/j.pcad.2009.12.003_bib28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2009.12.003_bib29","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2009.12.003_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2009.12.003_bib31","first-page":"15","article-title":"Antiproteinuric efficacy of eplerenone, enalapril and eplerenone\/enalapril combination in diabetic hypertensives with microalbuminuria","volume":"24A","author":"Epstein","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.003_bib32","first-page":"A1640","article-title":"Eplerenone, a new selective aldosterone receptor antagonist (SARA): efficacy in patients with mild to moderate hypertension","volume":"9","author":"Epstein","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pcad.2009.12.003_bib33","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2009.12.003_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"A transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2009.12.003_bib35","series-title":"Agonist\/antagonist activity of cortisol in cardiomyocyte mineralocorticoid receptors is determined by redox state. 30th Annual Meeting of the International Aldosterone Conference","year":"2004"},{"key":"10.1016\/j.pcad.2009.12.003_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tem.2004.03.006","article-title":"Is aldosterone bad for the heart?","volume":"15","author":"Funder","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pcad.2009.12.003_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2009.12.003_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.003_bib39","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1633591100","article-title":"Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor","volume":"100","author":"Fjeld","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2009.12.003_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pcad.2009.12.003_bib41","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in DOC\/salt rats","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinol"},{"key":"10.1016\/j.pcad.2009.12.003_bib42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on the blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apoprotein E-deficient mice","volume":"41","author":"Kendar","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2009.12.003_bib43","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2009.12.003_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.0000184640.81730.22","article-title":"Eplerenone inhibits atherosclerosis in nonhuman primates","volume":"46","author":"Takai","year":"2005","journal-title":"Hypertension"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062009001194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062009001194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T07:28:31Z","timestamp":1558942111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062009001194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0033062009001194"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2009.12.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}